Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 103

Results For "president"

1680 News Found

Lupin Diagnostics launches its first regional reference lab in Patna
Diagnostic Center | June 16, 2022

Lupin Diagnostics launches its first regional reference lab in Patna

Expanding diagnostics footprint in East India


Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
News | June 16, 2022

Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India

Glenmark is the first company in India to market the innovative FDC of Indacaterol


80% of hypertensive women found to be obese: Study
Healthcare | June 16, 2022

80% of hypertensive women found to be obese: Study

48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs


ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer
People | June 15, 2022

ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer

Gilman will be responsible for all business development and portfolio strategy efforts globally.


Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions
Supply Chain | June 15, 2022

Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions

Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals


Thermo Fisher Scientific launches new MS-based solutions
News | June 14, 2022

Thermo Fisher Scientific launches new MS-based solutions

Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities


FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Drug Approval | June 14, 2022

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial


Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants
News | June 14, 2022

Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants

Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile


Quizartinib Plus chemotherapy significantly improved overall survival compared to chemo
News | June 12, 2022

Quizartinib Plus chemotherapy significantly improved overall survival compared to chemo

Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium


Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis
Diagnostic Center | June 12, 2022

Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis

Amarex Clinical Research guides its client to phase II of FDA trials